This receptor type is EXPRESSED IN MANY CENTRAL AND PERIPHERAL TISSUES. This subtype show INCREASED PLATELET AGGREGATION and INCREASED CAPILLARY PERMEABILITY following exposure to serotonin. In CNS, these receptors are mainly present in basal ganglia. these antagonist are BEING DEVELOPED FOR THE TREATMENT OF SCHIZOPHRENIA.